Moderna and Pfizer-BioNTech Vaccines Prime T Cells to Fight SARS-CoV-2 Variants

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.lji.org/news-events/news/post/moderna-and-pfizer-biontech-vaccines-prime-t-cells-to-fight-sars-cov-2-variants/
Research Institution
La Jolla Institute for Immunology
Short Title
Moderna and Pfizer-BioNTech Vaccines Prime T Cells to Fight SARS-CoV-2 Variants
Content Coordinator
Claudia Wair
Content Manager
Kathy Donbeck